Atea Pharmaceuticals, Inc.
AVIR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $301,490 | $254,626 | $282,951 |
| - Cash | $77,344 | $87,721 | $119,394 | $64,696 |
| + Debt | $213 | $1,246 | $1,445 | $1,642 |
| Enterprise Value | – | $215,015 | $136,677 | $219,897 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$2,419 | -$3,440 | -$104 |
| % Margin | – | – | – | – |
| EBITDA | -$41,749 | -$41,319 | -$38,937 | -$33,214 |
| % Margin | – | – | – | – |
| Net Income | -$42,049 | -$37,161 | -$34,272 | -$33,543 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.53 | -0.44 | -0.4 | -0.4 |
| % Growth | -20.5% | -10% | 0% | – |
| Operating Cash Flow | -$40,375 | -$32,870 | -$30,563 | -$30,397 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$40,375 | -$32,870 | -$30,563 | -$30,397 |